Synapse Medicine

What They Do

Digital prescription and medication management platform helping healthcare professionals prescribe safely and manage drug interactions.

Funding

Valuation: Series B+; est. ~€50-100M Series B+. Backed by BPI France, Elaia Partners.

Business Details

• Founded: 2017
• Total Funding: $28M+
• Valuation: ~€50-100M (est.)
• Revenue: N/A (private)
• Employees: ~50-80 (est.)
• Key Milestones: $28M raised (TechCrunch reported). Medication intelligence platform. E-prescription safety.

See Also

• AIDAVA Competitive Analysis
• AIDAVA Related Companies
• Lifen
• France
• Digital Prescription